Clinical Pharmacology Consultant

Entrada Therapeutics, Inc.; Boston (MA); Teletrabalho; USD 150 000 - 210 000; Tempo integral

Resumo da oferta

Entrada Therapeutics, Inc. is seeking a dynamic Clinical Pharmacology Consultant to join our clinical stage programs remotely in the United States.

The ideal candidate will bring extensive clinical pharmacology expertise and a strong background in study design within biotech/pharma, translating science into approved medicines. You will report to the Head of Clinical Pharmacology and collaborate with Clinical Development, Biostatistics, and Regulatory teams to deliver PK/PD analyses, regulatory

Qualificações

• MS 8+ years or Ph.D. and 3 + years in pharmaceutical sciences, pharmacology, pharmacometrics, pharmacokinetics, or related discipline.
• Publication record with a demonstrated technical exposure to early exploratory trials through Phase 2/3 programs preferred.
• Experience using Phoenix WinNonlin, R, NONMEM, MATLAB, or other pharmacokinetic and modeling software.

Responsabilidades

• Provide clinical pharmacology input to regulatory documents and participate in clinical study design and documentation.
• Independently lead and oversee analysis, interpretation, integration and reporting of PK/PD data.
• Collaborate with Clinical Development, Biostatistics, Non-Clinical Product Development, Clinical Operations, and Regulatory to deliver on objectives.
• Monitor work with CROs and external vendors to ensure compliance with protocols and timelines.

Conhecimentos

Clinical pharmacology

Study design

PK/PD analysis

Cross-functional collaboration

Formação académica

MS with 8+ years experience

PhD with 3+ years experience

PharmD or MD with relevant experience

Ferramentas

Phoenix WinNonlin

R

NONMEM

MATLAB

Descrição da oferta de emprego

What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1).

2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670).

We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families.

The Opportunity

We are seeking a dynamic Clinical Pharmacology Consultant who will bring extensive expertise in clinical pharmacology to our clinical stage programs. The ideal candidate will have a strong background in study design within the biotechnology or pharmaceutical industry and be passionate about translating science into approved and accessible medicines. You will report directly to the Head of Clinical Pharmacology and partner closely with various functions of our growing organization.

Responsibilities

• Provide clinical pharmacology input to regulatory documents, participate in clinical study design and documentation (lab manuals, protocols, SAPs, etc).
• Independently lead and oversee the analysis, interpretation, integration and reporting of clinical pharmacokinetic & pharmacodynamic data of assigned projects.
• Work collaboratively with functional partners, including Clinical Development, Biostatistics, Non-Clinical Product Development, Clinical Operations, and Regulatory to deliver on both project team and corporate objectives.
• Monitor work with CROs and other external vendors to ensure compliance with agreed protocols, quality standards, and timelines

The Necessities

At Entrada, our passion for science, our devotion to patients and our values drives ourbehavior:

• Humanity - We genuinely care about patients and about one another.
• Tenacity - We are relentless and persistent in the pursuit of developing therapiesfor patients.
• Creativity - We are creative problem solvers.
• Collaboration - We are more than the sum of our parts.
• Curiosity - We have a growth mindset and push conventional thought and theory.

To thrive on our team, you will need to come with:

• MS 8+ years or Ph.D. and 3 + years in pharmaceutical sciences, pharmacology, pharmacometrics, pharmacokinetics, or related discipline or Pharm.D. or M.D. with relevant experience.
• Publication record with a demonstrated technical exposure to early exploratory trials through Phase 2/3 programs preferred.
• Experience using Phoenix WinNonlin, R, NONMEM, MATLAB, or other pharmacokinetic and modeling software.
• Compartmental PK/PD modeling experience is a plus.
• Strong mathematical model development and analytical skills.

This is a US based remote contract position, looking for support from 30-40 hours per week #LI-Remote #LI-JF1

Equal Opportunity Employer

Entrada Therapeutics is an equal opportunity employer. Qualified candidates will receive consideration for employment without regard to race, color, religion, national origin, gender, sexual orientation, gender identity or expression, age, mental or physical disability, and genetic information, marital status, citizenship status, military status, protected veteran status or any other category protected by law.

Third Party Staffing Agencies

Entrada does not accept unsolicited resumes from any source other than directly from candidates. For the protection of all parties involved in the recruiting process, resumes will only be accepted from recruiters/agencies if a signed agreement is in place at the inception of the recruiting effort and authorized for a specified position. Unsolicited resumes sent to Entrada from recruiters/agencies do not constitute any type of relationship between the recruiter/agency and Entrada and does not obligate Entrada to pay fees if we hire from those resumes.

Privacy Statement

Entrada Therapeutics, Inc. (the "Entrada", "we," "us," or "our") respects your privacy and we want you to be familiar with how we collect, use, share, or otherwise process, your Personal Information. Please reference our privacy statement here to understand how and when your data is being used.